KMDA Q2 2023 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$520M

Q2 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$37M+58.7% YoY

Gross Profit

$14M38.6% margin

Operating Income

$3M7.0% margin

Net Income

$2M4.8% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+21.9%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$770,000

Stock-Based Comp.

$214,000

Balance Sheet

Total Assets

$314M

Total Liabilities

$138M

Stockholders' Equity

$177M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$24M	+58.7%
Gross Profit	$14M	$7M	+99.4%
Operating Income	$3M	-$2M	+214.7%
Net Income	$2M	-$4M	+146.2%